4D Molecular Therapeutics, Inc.
Status: Publicly traded
Direct answer
4D Molecular Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FDMT.
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye conditions), cardiology (heart ailments), and pulmonology (respiratory disorders). Within its active pipeline, three specific...
Can you invest in 4D Molecular Therapeutics, Inc.?
Yes. 4D Molecular Therapeutics, Inc. trades publicly on NASDAQ as FDMT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for 4D Molecular Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.